info@mail.ucallm.com
Transfection efficiency is not determined by a single factor. Instead, it is influenced by multiple aspects, including cell condition, nucleic acid quality, transfection reagent, complex formation, transfection conditions, and post-transfection culture. The optimal conditions can vary significantly depending on the cell type and nucleic acid. Therefore, establishing a stable and efficient transfection system generally requires systematic optimization. The following factors are key to achieving optimal transfection results.
1. Select Cells in Good Condition
Cell condition is a fundamental factor affecting both transfection efficiency and cell viability. Before transfection, cells should be healthy and actively growing, with no obvious contamination, normal morphology, and good attachment. For adherent cells, it is generally recommended to perform transfection when cells are in the logarithmic growth phase. Over-confluent cells may exhibit reduced proliferation, which can decrease nucleic acid uptake and expression efficiency, whereas excessively low cell density may result in unstable cell conditions and increased transfection-related toxicity.
Different cell types have different tolerances to transfection conditions. For example, common cell lines such as HEK293 and HeLa are generally relatively easy to transfect. For primary cells and stem cells, particular attention should be paid to post-transfection cell survival, proliferation, and phenotypic changes to avoid compromising their normal biological characteristics during the transfection process. For neuronal cells, especially mature neurons, transfection conditions should be optimized to minimize cellular stress and preserve neurite morphology. For immune cells such as T cells, B cells, and NK cells, appropriate delivery methods should be selected based on their suspension growth characteristics, low proliferation rates, or sensitivity to external stimulation, while post-transfection cell viability and functional status should also be evaluated.
During optimization, reporter genes such as GFP and RFP can be used initially to evaluate nucleic acid delivery efficiency, combined with cell viability, morphology, and functional indicators for comprehensive assessment. When conventional lipid- or polymer-mediated transfection does not achieve satisfactory results, different types of chemical transfection reagents can be compared, or alternative delivery methods such as electroporation/nucleofection or viral transduction can be considered according to the characteristics of the target cells. The ultimate goal is not simply to achieve the highest transfection rate, but to establish an efficient, low-toxicity, stable, and reproducible transfection condition suitable for the specific cell type while maintaining normal cell health and function.
2. Control the Appropriate Cell Density
Cell density directly affects cell growth status, the probability of contact with transfection complexes, and the final expression level. When cell density is too low, cell growth may become unstable, transfection-related cytotoxicity may become more pronounced, and experimental reproducibility may decrease. When cell density is too high, cell proliferation may slow down, nucleic acid uptake may be affected, and post-transfection expression levels may decrease.
Therefore, the appropriate seeding density should be determined according to the cell type, culture dish or plate format, and the transfection reagent manufacturer's instructions, while ensuring consistent cell numbers across experimental groups. For experiments requiring condition optimization, cell density can be treated as an independent variable and evaluated using a density gradient.
3. Ensure Nucleic Acid Quality
Nucleic acid quality is an important prerequisite for achieving consistent transfection results. For DNA transfection, attention should be paid to DNA purity, DNA integrity, endotoxin levels, DNA concentration, and concentration accuracy. For siRNA transfection, key factors include siRNA purity, sequence specificity, storage and freeze-thaw conditions, and siRNA concentration. For mRNA and other RNA-based transfection materials, particular attention should also be paid to RNA integrity and RNase contamination.
High-quality nucleic acids can not only improve transfection efficiency but also help reduce nonspecific cytotoxicity and experimental variability.
4. Select an Appropriate Transfection Reagent According to the Nucleic Acid Type
Different types of nucleic acids have distinct physicochemical properties and therefore require delivery systems that are appropriate for the specific experimental purpose. For example, although DNA and siRNA transfection are both forms of non-viral nucleic acid delivery, their optimal transfection reagents and optimization parameters may not necessarily be the same.
Therefore, it is recommended to prioritize transfection systems specifically developed or optimized for the target nucleic acid type.
Nucleic Acid Type | Common Transfection Methods | Typical Applications |
DNA Plasmid | Lipid-mediated, polymer-mediated transfection | Gene overexpression, reporter gene expression, protein expression |
siRNA | Lipid-, peptide-, polymer-mediated transfection | Gene knockdown, gene function studies |
miRNA | Lipid-, polymer-mediated transfection | miRNA mimic/inhibitor studies, gene regulation studies |
mRNA | Lipid-mediated or other non-viral delivery methods | Transient protein expression, cell reprogramming, functional studies |
CRISPR/Cas-related Nucleic Acids | Lipid-mediated transfection, electroporation/nucleofection, etc. | Gene editing, gene knockout, gene knock-in, gene function validation |
5. Optimize the Nucleic Acid-to-Transfection Reagent Ratio
This is one of the most critical parameters in chemical transfection optimization. Lipid- or polymer-based transfection reagents typically need to form complexes with nucleic acids before being taken up by cells for intracellular delivery. Too little nucleic acid may result in insufficient expression, whereas excessive amounts of transfection reagent may increase cytotoxicity. Therefore, it should not be assumed that more transfection reagent always leads to higher transfection efficiency. In practice, an optimal balance between transfection efficiency and cell viability needs to be identified. A matrix-based optimization approach is recommended, using different nucleic acid concentrations, transfection reagent concentrations, and nucleic acid-to-reagent ratios, while simultaneously evaluating transfection efficiency and cell viability to identify the condition with the best overall performance.
6. Properly Prepare Nucleic Acid–Transfection Reagent Complexes
For lipid- or polymer-mediated transfection, the formation of nucleic acid–transfection reagent complexes directly affects delivery efficiency. The general workflow includes: nucleic acid preparation → transfection reagent dilution → mixing → sufficient complex formation → addition to cells.
During preparation, pay attention to the following: use the recommended dilution buffer, maintain accurate concentrations of both nucleic acid and transfection reagent, follow the recommended mixing order, control the complexation time, and avoid vigorous handling that may destabilize the complexes. The complex formation conditions may vary among different types of transfection reagents, so the specific product instructions should be followed whenever possible.
7. Optimize the Culture Medium and Transfection Conditions
The composition of the culture medium can also affect transfection efficiency. Some transfection systems are sensitive to serum, antibiotics, medium composition, pH, and ionic conditions. Therefore, when using a new transfection reagent, experiments should initially be performed under the culture conditions recommended in the product instructions. In particular, avoid changing the serum concentration, antibiotics, or medium type without prior validation. For some systems, transfection can be performed directly in serum-containing medium, whereas other systems may recommend specific conditions for complex preparation or treatment.
8. Set Appropriate Control Groups
A reliable transfection experiment should not only determine whether expression occurs, but also determine whether the observed changes result from the nucleic acid itself or from the transfection process. Appropriate controls should be included according to the experimental purpose. Common controls include:
Untreated Control: Untreated cells used to evaluate the baseline cellular state.
Transfection Reagent Control: Cells treated with transfection reagent without nucleic acid, used to evaluate the cytotoxicity of the transfection reagent itself.
Negative Control: Cells treated with an irrelevant sequence or negative-control nucleic acid, used to assess nonspecific effects.
Positive Transfection Control: A validated positive transfection material used to determine whether the transfection system is functioning properly.
Reporter Control: GFP, RFP, Luciferase, or other reporter systems used to evaluate transfection efficiency.
These controls help distinguish among transfection efficiency, cytotoxicity, and nucleic acid-specific effects.
9. Use Reporter Genes to Rapidly Evaluate Transfection Efficiency
For a new cell type, new transfection reagent, or new experimental system, it is recommended to first use a reporter gene for condition optimization. Common reporter systems include GFP, RFP, Luciferase, and β-galactosidase. GFP/RFP can be directly used to determine the percentage of positive cells by fluorescence microscopy or flow cytometry, whereas Luciferase can be used to quantitatively evaluate expression levels through luminescence signals.
For example, transfection efficiency can be evaluated based on the percentage of GFP-positive cells, together with cell viability, defined as the proportion of viable cells after transfection, to identify the optimal transfection condition.
10. Evaluate Both Transfection Efficiency and Cell Viability
A high transfection rate does not necessarily indicate the optimal condition. For example, if a condition produces a high percentage of fluorescent-positive cells but also causes substantial cell death, it is generally not suitable for subsequent functional experiments. Therefore, optimization should focus on finding the best balance among high transfection efficiency, high cell viability, and good reproducibility.
11. Optimize Conditions for Different Cell Types
There is no universal transfection condition that works equally well for all cell types. For common cell lines, optimization can initially begin with the conditions recommended by the product manufacturer. For hard-to-transfect cells, parameters may need to be adjusted more systematically. Key optimization factors include: cell density → nucleic acid amount → transfection reagent amount → nucleic acid-to-reagent ratio → culture conditions → transfection time.
For primary cells, stem cells, and other sensitive cell types, particular attention should also be paid to post-transfection cell viability, cell morphology, proliferation capacity, differentiation status, and subsequent cellular functions.
12. Determine the Detection Time According to the Experimental Purpose
Different nucleic acids have different expression kinetics, so the appropriate detection time after transfection cannot be standardized across all experiments. For example:
Plasmid DNA: Typically used to achieve transient gene expression.
siRNA: Requires the RNA interference process before significant gene knockdown can be observed.
mRNA: Can generally produce protein expression relatively rapidly.
Gene editing systems: Detection time should be determined based on editing efficiency and changes in the target gene.
Therefore, appropriate detection time points should be selected according to the specific experimental purpose rather than using a fixed time point for all transfection experiments.
13. Start with Small-Scale Optimization Before Formal Experiments
When using a transfection reagent for the first time or working with a new cell type, it is not recommended to immediately perform large-scale experiments. Instead, begin with small-scale systems such as 24-well, 48-well, or 96-well plates for condition screening.
For example, different combinations of cell density × nucleic acid amount × transfection reagent amount can be evaluated using a fluorescent reporter gene together with cell viability measurements. Once the optimal condition has been identified, it can then be scaled up to 6-well plates → 10-cm dishes → multi-well plates → high-throughput experiments. This approach can significantly reduce reagent and sample consumption while minimizing the risk of failure in subsequent formal experiments.